谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 568 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Efficacy and Safety of CT-P39, an Omalizumab Biosimilar, in Chronic Spontaneous Urticaria: 16-Week Follow-Up Study
Clive Grattan, Yevgeniya Dytyatkovska, Michał Springer, Maria Ratkova, Borislava Krusheva, Izabella Krupa-Borek,Grazyna Pulka, Marta Chełmińska,Adam Reich, Sunghyun Kim, Yunju Bae, Suyoung Kim, Sewon Lee, Eunjin An, Jeong Eun Park, Jieun Ka, Jongho Kim, Sarbjit S Saini
Clinical and translational allergyno. 6 (2025): e70069-e70069
引用0浏览0WOS引用
0
0
Evaluating Remibrutinib in the Treatment of Chronic Spontaneous Urticaria
Agnieszka Bożek,Adam Reich
Immunotherapypp.1-6, (2025)
引用0浏览0WOS引用
0
0
Does Skin Color Matter in Psoriasis
Adam Reich
International journal of dermatologyno. 4 (2025): 635-636
引用0浏览0WOS引用
0
0
CT-P39 Compared with Reference Omalizumab in Chronic Spontaneous Urticaria: Results from a Double-Blind, Randomized, Active-Controlled, Phase 3 Study
Sarbjit S. Saini,Marcus Maurer, Yevgeniya Dytyatkovska, Ewa Springer, Maria Ratkova, Borislava Krusheva,Chun Wook Park, Grazyna Pulka, Marta Chelminska,Adam Reich,Sunghyun Kim,Keumyoung Ahn,Suyoung Kim, Sewon Lee, Jieun Ka, Jongho Kim,Clive Grattan
ALLERGY (2025)
引用0浏览0WOS引用
0
0
Breaking the Itch Cycle: Long-Term Effects of Nemolizumab in Prurigo Nodularis
Kamila Kędra,Adam Reich
The British journal of dermatology (2025)
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 568

#Citation: 10852

H-Index: 52

G-Index: 89

Sociability: 8

Diversity: 3

Activity: 84

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn